Diabetes is a significant health-care challenge. According to the Centers for Disease Control, 30.4 million Americans have diabetes, and one-in-four of them don’t know they have it. There are 84 million people with pre-diabetes, according to the CDC. What is your practice doing to serve these people? Not only is taking care of these patients by addressing their diabetes the right thing to do; it’s a great practice-builder.
A serious, irreversible eye disease known as myopic maculopathy is on the rise.
A serious, irreversible eye disease known as myopic maculopathy is on the rise.
In a bold fusion of fashion and technology, the generative AI fashion show exhibits emerging technology to create ultra-realistic models, ushering in what we believe will be a new era for product marketing and immersive visual storytelling. Each virtual model is wearing an actual pair of Lucyd glasses, seamlessly integrated into an entirely AI-generated runway sequence.
Artificial intelligence is more readily available than ever before to improve patient care and business operations in optometry.
Neuroscientists reveal that the part of the brain that receives and processes visual information in sighted people develops a unique connectivity pattern in people born blind. They say this pattern in the primary visual cortex is unique to each person -- akin to a fingerprint.
https://eyezoneinternational.com/wp-content/uploads/2024/11/WhatsApp-Video-2024-11-16-at-2.41.13-AM.mp4Share this post This is the headingLorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
New Horizons in Optometry: The 9th Saudi Optometry Conference and OptiVision Exhibition
The IAPB World Sight Day Photo Competition invites amateur and professional photographers to demonstrate their skills and share with the world what they see and what it means to #LoveYourEyes.
Researchers have found that taking a daily supplement containing antioxidant vitamins and minerals slows progression of late-stage dry age-related macular degeneration (AMD).